ARTICLE SUMMARY:
This interview with the leaders of the Medical Device Innovation Consortium—Andy Fish, Chip Hance, and Andrew Cleeland—highlights the broad bandwidth of the organization’s partnership with industry and regulators, and the opportunities these relationships provide for companies of all sizes.
When looking to identify prospective resources to help navigate the industry’s complex regulatory and reimbursement pathways, device companies are accustomed to reaching out to the medtech trade associations AdvaMed and MDMA (Medical Device Manufacturers Association). A less well-known, but potentially equally valuable asset is the Medical Device Innovation Consortium (MDIC). A panel at last November’s Medtech Strategist San Francisco Innovation Summit featured the leadership of MDIC highlighting the broad nature of the organization’s resources and explaining how large and small product companies can benefit from these efforts.
